Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person14
First Foundation Inc.
Company
Saints Foundation
Company · 04312794
FIRST SOLAR, INC.
Company
First Breach, Inc.
Company
Walsall FC Foundation
Company · 04077345
FIRST CAPITAL INC
Company
FIRST HAWAIIAN, INC.
Company
National Energy Foundation
Company · 02218531
First Bancorp, Inc /ME/
Company
FingerMotion, Inc.
Company
Firy Inc.
Company
MCS CHARITABLE FOUNDATION
Company · 10119873
BETTERWORLD FOUNDATION LTD
Company · 13005208
JOSEPH ROWNTREE FOUNDATION
Company · 12132713
Primary record16
bioAffinity Technologies, Inc. filed 8-K
Item 8.01. Other Events. On September 30, 2026, bioAffinity Technologies, Inc., a Delaware corporation (the Company ), issued a press release announcing that it has delivered the first joint exhibition of CyPath Lung und
FIRST UNITED CORP/MD/ filed 8-K
Item 5.02 Departure of Directors or Certain O cers; Election of Directors; Appointment of Certain O cers; Compensatory Arrangements of Certain O cers. (d) Director Election . Effective September 24, 2026, following a rec
RECURSION PHARMACEUTICALS, INC. filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. Recursion Pharmaceuticals, Inc. (the "Company") and Tempus AI, Inc. ("Tempus"), acknowledging the value of (i) Tempus s library of multimodal data and (ii) Recursion
Avalyn Pharma Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Director On September 15, 2026 (the Effective Da
BIMINI CAPITAL MANAGEMENT, INC. filed 8-K
ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On September 14, 2026, Richard H. Parry was appointed as a Clas
PDS Biotechnology Corp filed 8-K
Item 1.02 Termination of a Material Definitive Agreement. On September 14, 2026, PDS Biotechnology Corporation (the “ Company ”) redeemed in full that certain Promissory Note, dated as of June 15, 2026, as amended by tha
Solaris Energy Infrastructure, Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On September 1, 2026, Solaris Energy Infrastructure, Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement
Shutterstock, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (d) Election of Directors On September 4, 2026, the board of di
Pyxis Oncology, Inc. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Chief Executive Officer and Related Compensatio
NVIDIA CORP filed 8-K
Item 8.01. Other Events. On September 2, 2026, NVIDIA Corporation ( NVIDIA ) entered into a definitive agreement to acquire Hugging Face, Inc. ( Hugging Face ). Hugging Face operates a platform and community for developi
BOXABL Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On August 25, 2026, BOXABL Inc. (the Company ) entered into a Product Purchase Agreement (the Agreement ) with LC Vegas Acquisitions, LLC (the Buyer ). The Agreement
First Foundation Inc. filed SCHEDULE 13G/A
0001214659-26-010347.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001214659-26-006404 0001867831 XXXXXXXX LIVE 4 Common Stock, par value $0.001 per share 06/30/2026 0001413837 First Foundation In
Avalyn Pharma Inc. filed SCHEDULE 13G
0001388325-26-000044.txt : 20260814 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0001388325 XXXXXXXX LIVE Voting Common Stock, par value $0.001 per share 06/30/2026 0001540171 Avalyn Pharma Inc. 05348Y105 105 W Firs
MASTEC INC filed SCHEDULE 13D/A
0001193125-26-349228.txt : 20260813 SCHEDULE 13D/A 1 primary_doc.xml X0202 SCHEDULE 13D/A 0001079760 XXXXXXXX LIVE 5 Common Stock, Par Value $.10 Per Share 08/11/2026 false 0000015615 576323109 MasTec, Inc. 800 S. Dougla
Sprinklr, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Director Appointment On August 10, 2026, the Board of Directors
MASTEC INC filed SCHEDULE 13D/A
0001193125-26-349231.txt : 20260813 SCHEDULE 13D/A 1 primary_doc.xml X0202 SCHEDULE 13D/A 0000920559 XXXXXXXX LIVE 10 Common Stock, Par Value $.10 Per Share 08/11/2026 false 0000015615 576323109 MasTec, Inc. 800 S. Dougl